Apollo Hospitals Enterprise Limited appears to be a financially healthy company with a strong growth trajectory, evidenced by its revenue growth of 13.1% and earnings growth of 53.5%. The company's profitability metrics, such as ROE and profit margins, are also respectable. However, the company's valuation seems rich, with a trailing P/E of 69.43 and forward P/E of 85.86, indicating that the stock may be overpriced. A concern is the high debt-to-equity ratio of 90.89, which may pose a risk to the company's financial stability. Overall, the company's strengths in growth and profitability are offset by weaknesses in valuation and debt position.